David Hornigold

Take part in a structured networking debate exploring one of the field’s most important strategic questions: broad dual amylin/calcitonin receptor agonism versus more selective amylin receptor targeting. Compare the scientific rationale, translational evidence and perceived trade-offs behind each approach, challenge assumptions with peers, and build connections with developers working across both sides of the debate.